Cosmo Pharma
Price
Price
Historical dividends and forecast
Cosmo Pharma has so far distributed $4.351 in 2024. The next dividend will be paid on 30.05.2025
CHART BY
Frequently asked questions
What is Cosmo Pharma's market capitalization?
What is Cosmo Pharma's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Cosmo Pharma?
What are the analyst ratings and target price for Cosmo Pharma's stock?
What is Cosmo Pharma's revenue over the trailing twelve months?
What is the EBITDA for Cosmo Pharma?
What is the free cash flow of Cosmo Pharma?
What is the 5-year beta of Cosmo Pharma's stock?
How many employees does Cosmo Pharma have, and what sector and industry does it belong to?
What is the free float of Cosmo Pharma's shares?
Financials
Market Cap
$1.24B5Y beta
1.63EPS (TTM)
$4.512Free Float
7.75MP/E ratio (TTM)
15.66Revenue (TTM)
$193.62MEBITDA (TTM)
$105.11MFree Cashflow (TTM)
$97.63MPricing
Analyst Ratings
The price target is $99.74 and the stock is covered by 5 analysts.
Buy
5
Hold
0
Sell
0
Information
Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastrointestinal (GI) diseases and dermatology. Its development pipeline is focused on Bowel Diseases, Colon Infections, and products to reduce the incidence of Colorectal Cancer (CRC) by increasing the detection of cancerous and pre-cancerous lesions during colonoscopy. Products which it has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers’ diarrhoea (TD), Methylene Blue MMX, which is a new diagnostic drug to improve precancerous and cancerous lesion detection during colonoscopy and Winlevi for the treatment of acne. Its therapeutic focus is on the oral and endoscopic treatment of colon diseases.
339
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker